ArticleProceedings of the National Academy of Sciences of the United States of America2017
Correction for Dash et al., Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.